Sort   by:  
 Page size 
TranscriptomicsTranscriptome analysis reveals a major impact of Tyk2 on the expression of interferon responsive and metabolic genes
Peritoneal macrophages of Tyk2-/- and wildtype (wt) mice were compared before and after six hours of LPS treatment. Interferon responsive genes are lower expressed in Tyk2-/- macrophages at the basal level, metabolic genes higher before, but even more after LPS treatment. cDNA from macrophages from ...
ORGANISM(S): Mus musculus 
2010-04-01 | E-GEOD-19733 | biostudies-arrayexpress
TranscriptomicsComparison of the expression profiles of wild type (WT) and Oct-6-deficient (Oct-6-/-) macrophages in response to poly(I:C) treatment
Identification of target genes of the POU-transcription factor Oct-6 in macrophages after poly(I:C) treatment WT and Oct-6-/- fetal-liver macrophages were treated with poly(I:C) for 8 hours or were left untreated (3 independent expreiments = biological replicates). 200 genes differentially regulated...
ORGANISM(S): Mus musculus 
2010-08-01 | E-GEOD-22691 | biostudies-arrayexpress
Unknown[Effects of the COVID-19 pandemic on inpatient dermatosurgery in Germany : Retrospective evaluation of the surgical cases from nine dermatology clinics].
Not available
S-EPMC11538252 | biostudies-literature
UnknownAnalysis of microplastics in drinking water and other clean water samples with micro-Raman and micro-infrared spectroscopy: minimum requirements and best practice guidelines.
Not available
S-EPMC8440246 | biostudies-literature
UnknownFirst outline and baseline data of a randomized, controlled multicenter trial to evaluate the health economic impact of home telemonitoring in chronic heart failure - CardioBBEAT.
Not available
S-EPMC4531517 | biostudies-literature
UnknownSARS-CoV-2 mRNA vaccination-induced immunological memory in human nonlymphoid and lymphoid tissues.
Not available
S-EPMC10721158 | biostudies-literature
UnknownInvasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Not available
S-EPMC12496005 | biostudies-literature
UnknownLong-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Not available
S-EPMC10853028 | biostudies-literature
Sort   by:  
 Page size